• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

UCB lowers 2022 profit expectations amid Ukraine war, rising costs

cafead

Administrator
Staff member
  • cafead   Jun 27, 2022 at 10:12: AM
via Generic competition, a complete response letter, a new acquisition and external pressures have created a perfect storm for UCB, leading the company to reduce its profit forecast for 2022.

After previously projecting a profit margin of 26% to 27% and earnings per share of €4.80 to €5.30 this year, UCB has revised those ranges to 21% to 22% and €3.70 to €4, respectively.

article source
 

<